Lepu Biopharma Co. Ltd. Class H(HK:2157)
HK$2.70-0.10 (-3.57%)
HK:2157
Lepu Biopharma Co. Ltd. Class H financials statements
HK$2.70
At close:-0.10 (-3.57%)
Want to see HK:2157 full AI Analyst Report?
Lepu Biopharma Co. Ltd. Class H (2157) Income Statement
4 Followers
Lepu Biopharma Co. Ltd. Class H Income Statement
Last quarter (Q2 2026), Lepu Biopharma Co. Ltd. Class H's total revenue was ¥515.20M, an increase of 286.17% from the same quarter last year. In Q2, Lepu Biopharma Co. Ltd. Class H's net income was ¥27.01M. See Lepu Biopharma Co. Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 910.67M | ¥ 367.79M | ¥ 225.35M | ¥ 15.57M | ¥ 0.00 | |
| ¥ 732.10M | ¥ 292.97M | ¥ 197.07M | ¥ 13.57M | ¥ -114.79M | |
| ¥ 644.67M | ¥ 683.74M | ¥ 192.28M | ¥ 718.05M | ¥ 1.01B | |
| Depreciation and Amortization | ¥ 91.30M | ¥ 100.18M | ¥ 102.57M | ¥ 95.45M | ¥ 95.25M |
| ¥ 178.73M | ¥ -295.67M | ¥ 86.95M | ¥ -596.53M | ¥ -848.43M | |
| ¥ 87.43M | ¥ -390.76M | ¥ 4.80M | ¥ -704.48M | ¥ -1.01B | |
| ¥ 166.46M | ¥ -33.43M | ¥ -35.10M | ¥ 5.04M | ¥ -19.23M | |
| ¥ 253.89M | ¥ -424.19M | ¥ -30.30M | ¥ -699.44M | ¥ -1.03B | |
| ¥ 254.60M | ¥ -411.38M | ¥ -22.10M | ¥ -689.05M | ¥ -1.01B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 0.14 | ¥ -0.24 | ¥ -0.01 | ¥ -0.42 | ¥ -0.61 |
| Diluted EPS | ¥ 0.14 | ¥ -0.24 | ¥ -0.01 | ¥ -0.42 | ¥ -0.61 |
| Weighted Average Shares Outstanding | 1.76B | 1.69B | 1.66B | 1.64B | 1.66B |
| Weighted Average Shares Outstanding (Diluted) | 1.76B | 1.69B | 1.66B | 1.64B | 1.66B |
Currency in CNY
